fluorodeoxyglucose f18 has been researched along with Pituitary Neoplasms in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (4.76) | 18.2507 |
2000's | 7 (16.67) | 29.6817 |
2010's | 22 (52.38) | 24.3611 |
2020's | 11 (26.19) | 2.80 |
Authors | Studies |
---|---|
Amrane, K; Campedel, L; Kharroubi, D; Le Meur, C | 1 |
Im, SW; Ishii, K; Kaida, H; Kashiwagi, N; Matsukubo, Y | 1 |
Aloj, L; Bashari, W; Cheow, H; Crawford, R; Gillett, D; Gurnell, M; Harper, I; MacFarlane, J; Mendichovszky, IA | 1 |
Bogusławska, A; Gamrat, A; Gilis-Januszewska, A; Hubalewska-Dydejczyk, A; Minasyan, M; Rzepka, E | 1 |
Kim, DK; Kim, EH; Kim, K; Kim, SH; Ku, CR; Lee, EJ; Moon, JH | 1 |
Cheng, X; Kong, Z; Ma, W; Wang, Y | 1 |
Abe, K; Ishizaki, U; Masui, K; Sakai, S; Takako, K | 1 |
Ding, L; He, Q; Li, R; Li, Z; Shi, X; Zhang, F; Zhang, X | 1 |
Annovazzi, A; Annunziata, S; Bergomi, S; Pasqualoni, R; Sciuto, R | 1 |
Mester, A; Piciu, A; Piciu, D | 1 |
Decoudier, B; Dejust, S; Higel, B; Litre, CF; Morland, D | 1 |
Bogosavljević, V; Doknić, M; Kozarević, N; Manojlović-Gačić, E; Miljić, D; Milojević, T; Pekić, S; Petakov, M; Petrović, N; Popović, V; Skender-Gazibara, M; Stojanović, M | 1 |
D'Amico, D; Fonti, R; Salvatore, B | 1 |
Alongi, P; Del Vecchio, A; Di Muzio, N; Gerevini, S; Gianolli, L; Iaccarino, L; Losa, M; Mortini, P; Perani, D; Plebani, V | 1 |
Hua, CH; Indelicato, DJ; Laser, BS; Merchant, TE; Shulkin, BL; Snyder, SE | 1 |
Agarwal, KK; Bal, C; Kumar, R; Sharma, P; Singla, S; Suman Kc, S | 1 |
Hou, Y; Jin, X; Wang, R; Xing, B; Zhu, Z | 1 |
Maiza, JC; Revel, C | 1 |
Datseris, IE; Skoura, E; Stratakis, CA; Tolis, G; Xekouki, P | 1 |
Li, F; Wang, R; Xiao, J; Xing, B; Zhao, X; Zhu, Z | 1 |
Chittiboina, P; Herscovitch, P; Lonser, RR; Millo, C; Montgomery, BK | 1 |
Chacko, AG; Devadhas, D; Heck, DK; Oommen, R; Rebekah, G; Samuel, EJ; Thomas T, HM | 1 |
Feng, Z; He, D; Mao, Z; Wang, H; Wang, Z; Zhang, X; Zhu, Y | 1 |
Cheng, X; Cui, R; Zhu, W | 1 |
Ryu, SI; Skirboll, SL; Tafti, BA | 1 |
Cai, L; Chen, QS; Gao, S; Li, DC; Li, YS; Xing, XL | 1 |
Al-Nahhas, A; El-Refai, S; Hodolic, M; Khan, S; Marzola, MC; Naji, M; Rubello, D | 1 |
Hayasaka, K; Koyama, M; Yamashita, T | 1 |
Appelbaum, DE; Ilkhchoui, Y; Pu, Y | 1 |
Balink, H; Collins, J; Gemmel, F; Oomen, P | 1 |
Ahn, BC; Cho, IH; Chun, KA; Jeong, SY; Kang, S; Lee, HJ; Lee, J; Lee, SW; Seo, JH; Won, KS; Zeon, SK | 1 |
Choe, YS; Choi, JY; Hyun, SH; Kim, BT; Lee, KH | 1 |
Chondrogiannis, S; Dassie, F; De Carlo, E; Grassetto, G; Maffei, P; Marzola, MC; Massaro, A; Musto, A; Pelizzo, MR; Rampin, L; Rubello, D | 1 |
Cho, HJ; Choe, EY; Kim, JY; Kim, TS; Lee, EJ; Lee, EY; Lee, JD; Lim, SK; Rhee, Y; Seok, H; Shin, DY; Yang, WI; Yun, MJ | 1 |
Campeau, RJ; David, O; Dowling, AM | 1 |
Goldman, S; Levivier, M; Massager, N; Wikler, D | 1 |
Bhargava, P; Ghesani, M; Kagetsu, NJ; Koo, CW; Rajagopalan, V; Sims-Childs, H | 1 |
Aydin, C; Cakir, B; Dirikoc, A; Ersoy, R; Topaloglu, O | 1 |
Al-Nahhas, A; Khan, S; Lloyd, C; Rubello, D; Szyszko, T; Win, Z | 1 |
Black, M; Gjedde, A; Yamamoto, YL; Zeitouni, AG | 1 |
Hasegawa, S; Hirata, M; Hori, M; Nishimura, T; Tokita, N; Yamaguchi, H; Yoshioka, J | 1 |
Daemen, BJ; Doorenbos, H; Elsinga, PH; Paans, AM; Vaalburg, W; Zwertbroek, R | 1 |
3 review(s) available for fluorodeoxyglucose f18 and Pituitary Neoplasms
Article | Year |
---|---|
Molecular Imaging of Pituitary Tumors.
Topics: Adenoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Molecular Imaging; Pituitary Neoplasms; Positron-Emission Tomography | 2023 |
Endocrine tumors: the evolving role of positron emission tomography in diagnosis and management.
Topics: Adrenal Gland Neoplasms; Adrenal Medulla; Carcinoma, Neuroendocrine; Catecholamines; Cushing Syndrome; Endocrine Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Organometallic Compounds; Parathyroid Neoplasms; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
PET imaging in endocrine tumours.
Topics: Adrenal Gland Neoplasms; Endocrine Gland Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neuroendocrine Tumors; Parathyroid Neoplasms; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2008 |
1 trial(s) available for fluorodeoxyglucose f18 and Pituitary Neoplasms
Article | Year |
---|---|
PET Evaluation of Late Cerebral Effect in Advanced Radiation Therapy Techniques for Cranial Base Tumors.
Topics: Brain; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Meningioma; Neuropsychological Tests; Pituitary Neoplasms; Positron-Emission Tomography; Radiosurgery; Skull Base Neoplasms | 2018 |
38 other study(ies) available for fluorodeoxyglucose f18 and Pituitary Neoplasms
Article | Year |
---|---|
Pituitary Metastasis of Non-Small Cell Lung Cancer With High FDG Uptake on PET/CT Pituitary Metastasis of Non-Small Cell Lung Carcinoma.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
High 18F-FDG Uptake in a Papillary Craniopharyngioma of the Third Ventricle.
Topics: Aged; Craniopharyngioma; Fluorodeoxyglucose F18; Humans; Male; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Third Ventricle | 2023 |
Ectopic, CRH-responsive Cushing syndrome with negative 68Ga-DOTATATE and 18F-FDG PET/CT imaging findings and pituitary microadenoma: a challenging case with a successful outcome.
Topics: Cushing Syndrome; Fluorodeoxyglucose F18; Humans; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Dexamethasone suppression for
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Dexamethasone; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Young Adult | 2023 |
FDG-PET/CT in the detection of pituitary stalk ACTH-secreting adenoma.
Topics: Adenoma; Adrenocorticotropic Hormone; Fluorodeoxyglucose F18; Humans; Pituitary Gland; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography | 2020 |
FDG PET/CT Findings of Ectopic Pituitary Adenoma.
Topics: Adenoma; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skull Base | 2020 |
Differentiation of suprasellar meningiomas from non-functioning pituitary macroadenomas by
Topics: Adenoma; Adult; Aged; Ammonia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Meningeal Neoplasms; Meninges; Meningioma; Middle Aged; Nitrogen Radioisotopes; Pituitary Gland; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
A Rare Case of Solitary Pituitary Metastasis From Spitzoid Melanoma Detected by FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2020 |
Pituitary Metastases Discovered by 18F-FDG PET/CT During Other Cancers Monitoring: Are There Any Differences of SUVs Between Benign and Malignant Diseases?
Topics: Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
Gonadotropin-Secreting Pituitary Macroadenoma Complicated With Hemorrhagic Apoplexy in 18F-FDG PET/CT.
Topics: Adenoma; Aged; Fluorodeoxyglucose F18; Gonadotropins; Hemorrhagic Stroke; Humans; Male; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
All that glitters on PET is not cancer! 18F-deoxy-glucose avidity versus tumor biology: pituitary incidentaloma in a survivor of two previous unrelated malignancies.
Topics: Adenoma; Aged; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography | 2017 |
Metastasis to the Sellar/Suprasellar Region in a Patient With Endometrial Carcinoma Detected by 18F-FDG PET/CT.
Topics: Aged; Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Evaluation of children with craniopharyngioma using carbon-11 methionine PET prior to proton therapy.
Topics: Adolescent; Adult; Child; Child, Preschool; Craniopharyngioma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Methionine; Pituitary Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Proton Therapy; Radiopharmaceuticals; Young Adult | 2013 |
A rare case of non-small cell lung cancer metastasizing to the pituitary gland: detection with (18)F-FDG PET-CT.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Pituitary Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Combined 18F-FDG PET/CT and 99mTc 3PRGD2 SPECT/CT imaging in a case of pituitary metastases.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Organotechnetium Compounds; Peptides, Cyclic; Pituitary Neoplasms; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2013 |
Evolution of (18)FDG pituitary uptake after medical control of acromegaly.
Topics: Acromegaly; Adenoma; Fluorodeoxyglucose F18; Hormone Antagonists; Humans; Pituitary Gland; Pituitary Neoplasms; Plasmacytoma; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin | 2014 |
SPECT and 18F-FDG PET/CT imaging of multiple paragangliomas and a growth hormone-producing pituitary adenoma as phenotypes from a novel succinate dehydrogenase subunit D mutation.
Topics: Adenoma; Adult; Fluorodeoxyglucose F18; Growth Hormone; Humans; Male; Multimodal Imaging; Mutation; Paraganglioma; Phenotype; Pituitary Neoplasms; Positron-Emission Tomography; Protein Subunits; Succinate Dehydrogenase; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Comparison of (68)Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomy.
Topics: Adenoma; Adult; Cicatrix; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Organometallic Compounds; Pituitary Gland; Pituitary Neoplasms; Radionuclide Imaging; Sphenoid Bone | 2014 |
High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Child; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2015 |
Adaptive threshold segmentation of pituitary adenomas from FDG PET images for radiosurgery.
Topics: Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Linear Models; Phantoms, Imaging; Pituitary Neoplasms; Positron-Emission Tomography; Radiosurgery; Retrospective Studies | 2014 |
Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning Pituitary Adenomas.
Topics: Adenoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Multimodal Imaging; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Increased 18F-2-Fluorodeoxysorbitol (18F-FDS) Activity in a Pituitary Spindle Cell Carcinoma.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sorbitol | 2016 |
Pituitary adenomas can appear as hypermetabolic lesions in (18) F-FDG PET imaging.
Topics: Adenoma; Aged; Brain Diseases, Metabolic; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
[Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
Topics: Acetates; Adolescent; Adult; Aged; Brain Abscess; Brain Neoplasms; Carbon; Carbon Radioisotopes; Child; Craniopharyngioma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2009 |
Primary pituitary lymphoma diagnosis by FDG-PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Pituitary Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
FDG-PET/CT findings of a metastatic pituitary tumor.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Insulin-Like Growth Factor I; Male; Pituitary Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Occult prolactinoma diagnosed by FDG PET/CT.
Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Pituitary Neoplasms; Positron-Emission Tomography; Prolactinoma; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Incidence; Korea; Male; Middle Aged; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Incidental focal 18F-FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria.
Topics: Adult; Aged; Aged, 80 and over; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, Emission-Computed; Whole-Body Counting | 2011 |
A very rare case of nonfunctioning pituitary adenoma incidentally disclosed at 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Pituitary Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tumor Burden; Young Adult | 2013 |
Pituitary adenoma detected on FDG positron emission tomography in a patient with mucosa-associated lymphoid tissue lymphoma.
Topics: Adenoma; Brain; Diagnosis, Differential; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Pituitary Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Whole-Body Counting | 2003 |
Modern multimodal neuroimaging for radiosurgery: the example of PET scan integration.
Topics: Adenoma; Brain; Brain Neoplasms; Contrast Media; Energy Metabolism; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neuronavigation; Phantoms, Imaging; Pituitary Neoplasms; Positron-Emission Tomography; Quality Control; Radiosurgery; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Incidental detection of clinically occult pituitary adenoma on whole-body FDG PET imaging.
Topics: Adenoma; Aged; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Neoplasms, Unknown Primary; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2006 |
Pituitary metastasis of breast cancer confirmed by fluorine-18 fluorodeoxyglucose positron emission tomography: a case report.
Topics: Breast Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Functional imaging of head and neck tumors using positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cerebellum; Cicatrix; Deoxyglucose; Female; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Necrosis; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Pituitary Neoplasms; Tomography, Emission-Computed; Tonsillar Neoplasms | 1994 |
Fluorine-18 FDG myocardial positron emission tomographic findings before and after pituitary adenoma resection in a patient with acromegalic cardiomyopathy.
Topics: Acromegaly; Adenoma; Cardiac Output, Low; Cardiomyopathy, Hypertrophic; Fluorodeoxyglucose F18; Follow-Up Studies; Gated Blood-Pool Imaging; Glucose; Heart; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Myocardium; Pituitary Neoplasms; Preoperative Care; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome; Ventricular Function, Left | 2000 |
PET studies with L-[1-11C]tyrosine, L-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocryptine treatment.
Topics: Adult; Bromocriptine; Carbon Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, Emission-Computed; Tyrosine | 1991 |